DarioHealth Corp. (NASDAQ:DRIO) Short Interest Down 11.4% in January

DarioHealth Corp. (NASDAQ:DRIO) was the target of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 2,710,000 shares, a decline of 11.4% from the January 15th total of 3,060,000 shares. Based on an average trading volume of 610,800 shares, the days-to-cover ratio is presently 4.4 days.

Hedge Funds Weigh In On DarioHealth

A number of hedge funds have recently bought and sold shares of the company. XTX Topco Ltd grew its stake in DarioHealth by 81.4% in the third quarter. XTX Topco Ltd now owns 29,455 shares of the company’s stock worth $33,000 after purchasing an additional 13,219 shares in the last quarter. Appian Way Asset Management LP grew its stake in DarioHealth by 2.5% in the third quarter. Appian Way Asset Management LP now owns 1,410,870 shares of the company’s stock worth $1,580,000 after purchasing an additional 34,990 shares in the last quarter. Finally, DLK Investment Management LLC grew its stake in DarioHealth by 40.9% in the fourth quarter. DLK Investment Management LLC now owns 141,657 shares of the company’s stock worth $111,000 after purchasing an additional 41,107 shares in the last quarter. 33.39% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, TD Cowen lowered DarioHealth from a “buy” rating to a “hold” rating and dropped their target price for the stock from $2.00 to $1.00 in a research report on Wednesday, January 29th.

DarioHealth Stock Up 3.0 %

Shares of NASDAQ DRIO traded up $0.02 during midday trading on Tuesday, reaching $0.72. 2,945,332 shares of the company’s stock were exchanged, compared to its average volume of 1,215,975. The stock has a market capitalization of $24.59 million, a PE ratio of -0.77 and a beta of 1.39. DarioHealth has a 52-week low of $0.56 and a 52-week high of $2.51. The business’s fifty day moving average price is $0.73 and its two-hundred day moving average price is $0.84. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.32 and a current ratio of 1.57.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.